• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Assessment of some variables affecting the blanching activity of betamethasone 17-valerate cream.

作者信息

Magnus A D, Haigh J M, Kanfer I

出版信息

Dermatologica. 1980;160(5):321-7. doi: 10.1159/000250513.

DOI:10.1159/000250513
PMID:7364141
Abstract

The effect of concentration and occlusion time on the ability of Betnovate cream (betamethasone 17-valerate 0.1%) to produce skin blanching was assessed. Generally, increased concentration or occlusion time produce an increase in the degree of blanching observed, however, a plateau stage is eventually reached where no further increase of blanching occurs.

摘要

相似文献

1
Assessment of some variables affecting the blanching activity of betamethasone 17-valerate cream.
Dermatologica. 1980;160(5):321-7. doi: 10.1159/000250513.
2
The stability and blanching efficacy of betamethasone-17-valerate in emulsifying ointment.
Br J Dermatol. 1982 Jul;107(1):71-6. doi: 10.1111/j.1365-2133.1982.tb00292.x.
3
The effect of serial dilution of betamethasone-17-valerate on blanching potential and chemical stability.
J Clin Hosp Pharm. 1983 Jun;8(2):143-5. doi: 10.1111/j.1365-2710.1983.tb01044.x.
4
Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerate creams.戊酸倍他米松乳膏的体内皮肤变白与体外释放速率之间的关系。
J Pharm Sci. 1992 Jan;81(1):104-6. doi: 10.1002/jps.2600810121.
5
Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
Dermatologica. 1976;153(4):236-42. doi: 10.1159/000251062.
6
Release of betamethasone 17-valerate from extemporaneous dilutions of a proprietary topical cream.从一种专利外用乳膏的临时稀释液中释放倍他米松 17-戊酸酯。
Dermatologica. 1981;163(4):331-7. doi: 10.1159/000250181.
7
The stability and blanching efficiency of some Betnelan-V cream dilutions.
J Clin Hosp Pharm. 1986 Apr;11(2):101-6. doi: 10.1111/j.1365-2710.1986.tb00833.x.
8
Comparison of the bioactivity of mometasone furoate 0.1% fatty cream, betamethasone dipropionate 0.05% cream and betamethasone valerate 0.1% cream in humans. Inhibition of UV-B-induced inflammation monitored by laser Doppler blood flowmetry.
Skin Pharmacol. 1993;6(3):187-92. doi: 10.1159/000211134.
9
Analysis of chromameter results obtained from corticosteroid-induced skin blanching assay: comparison of visual and chromameter data.对皮质类固醇诱导的皮肤变白试验所得色差计结果的分析:视觉数据与色差计数据的比较
Eur J Pharm Biopharm. 1999 May;47(3):261-7. doi: 10.1016/s0939-6411(98)00094-0.
10
Possible dosage regimens for topical steroids, assessed by vasoconstrictor assays using multiple applications.通过多次应用的血管收缩试验评估的局部用类固醇可能的给药方案。
Dermatologica. 1983;166(3):136-40. doi: 10.1159/000249855.

引用本文的文献

1
Assessment of dermal bioavailability: predicting the input function for topical glucocorticoids using stratum corneum sampling.皮肤生物利用度评估:利用表皮角质层取样预测局部皮质类固醇的输入函数。
Drug Deliv Transl Res. 2022 Apr;12(4):851-861. doi: 10.1007/s13346-021-01064-8. Epub 2021 Oct 1.
2
The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence, mechanisms and therapeutic modalities.新冠病毒与慢性疾病之间的动态关联:对患病率、机制和治疗方式的最新深入了解。
Infect Genet Evol. 2021 Jan;87:104647. doi: 10.1016/j.meegid.2020.104647. Epub 2020 Nov 29.
3
Evaluation of the proposed FDA pilot dose-response methodology for topical corticosteroid bioequivalence testing.
对美国食品药品监督管理局(FDA)提议的用于局部用皮质类固醇生物等效性测试的中剂量-反应方法的评估。
Pharm Res. 1997 Mar;14(3):303-8. doi: 10.1023/a:1012089803281.